ranimustine has been researched along with Erythrocytosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harashima, S; Okamura, T; Takaki, K; Umeno, M | 1 |
| Hirata, M; Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Shibata, H; Taniguchi, N; Tsubaki, K | 1 |
| Higuchi, A; Imamura, M; Kasai, M; Maekawa, I; Miyazaki, T; Morioka, M; Musashi, M; Ohtani, N; Saitoh, H; Sakurada, K | 1 |
3 other study(ies) available for ranimustine and Erythrocytosis
| Article | Year |
|---|---|
[A case of myelofibrosis that developed polycythemia vera following treatment with ranimustine and then acute myelogenous leukemia (M0)].
Topics: Antineoplastic Agents; Chromosome Aberrations; Chromosome Disorders; Disease Progression; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute; Lymphocyte Activation; Middle Aged; Nitrosourea Compounds; Polycythemia; Primary Myelofibrosis | 1996 |
[Phase II study on oral administration of MCNU (ranomustine) tablet. Hanshin Cooperative Study Group on Hematological Disorders].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Leukemia, Myeloid; Male; Middle Aged; Nitrosourea Compounds; Polycythemia; Tablets; Thrombocytosis | 1986 |
[Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Topics: Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia, Myeloid; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Polycythemia | 1985 |